Figure 1 — Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer

Navigate

Research Paper|Volume 16, Issue 8|pp. 7188–7216

Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer

Back to articleFigure 1(1 of 10)

100%

Figure 1.Flow chart of the screened and validated process.

Figure 1 — Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer | Aging